NewCo News: Mission Raises $9.8M for New Area of Enzymology
By Nuala Moran
Thursday, August 25, 2011
LONDON The scientists behind KuDOS Pharmaceuticals Ltd., which was sold to London-based AstraZeneca plc in December 2005 for £121.5 million (then US$210 million), have left the company to form another start-up, Mission Therapeutics Ltd.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.